Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius Medical Care Expands in China

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/05/2018 | 06:11am EDT

By Donato Paolo Mancini

Fresenius Medical Care AG & Co. KGaA (FME.XE) will acquire or has acquired majority stakes in a number of Chinese dialysis companies as it pushes plans to expand in China, the company said Wednesday.

Fresenius will acquire a 70% share in chronic-diseases-services company Guangzhou KangNiDaiSi Medical Investment Co. The company has also acquired 55% stakes in Henan Aishen Hospital Management Co. and Aishen Beijing Hospital Management Co. Both companies are active in the field of dialysis. They cover the Henan, Shandong, Guangdong and Hainan provinces, Fresenius said, with plans to expand in the future.

Fresenius has also taken a 60% share in Daqing Kangda Dialysis Center Co. in Heilongjiang.

Chronic kidney disease has a 10.8% prevalence in China, said Fresenius.

Write to Donato Paolo Mancini at donatopaolo.mancini@dowjones.com; @donatopmancini

Stocks mentioned in the article
ChangeLast1st jan.
FRESENIUS MEDICAL CARE AG & CO. KGAA 0.98% 70.38 Delayed Quote.24.26%
FRESENIUS SE & CO. KGAA 0.69% 46.8 Delayed Quote.10.43%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FRESENIUS MEDICAL CARE AG
07/15FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
07/10FRESENIUS MEDICAL CARE : sees U.S. plans for changes to kidney disease care as p..
PU
07/10FRESENIUS MEDICAL CARE : sees U.S. plans for changes to kidney disease care as p..
EQ
07/09Drugmakers Rise After Trump Pricing Rule Is Blocked
DJ
07/09Drugmakers Rise After Trump Pricing Rule Is Blocked
DJ
07/09FRESENIUS MEDICAL CARE : North America invests in innovative medical wearable ve..
PU
07/09FRESENIUS MEDICAL CARE : Invests in Medical Wearable Startup BioIntelliSense
DJ
07/08FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
07/03FRESENIUS MEDICAL CARE : expands clinical research activities
PU
07/03FRESENIUS MEDICAL CARE : Expands Frenova Clinical Research Activities
DJ
More news
Financials (USD)
Sales 2019 19 570 M
EBIT 2019 2 630 M
Net income 2019 1 335 M
Debt 2019 8 710 M
Yield 2019 1,62%
P/E ratio 2019 18,1x
P/E ratio 2020 15,1x
EV / Sales2019 1,67x
EV / Sales2020 1,55x
Capitalization 24 068 M
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 91,2  $
Last Close Price 79,3  $
Spread / Highest target 40,7%
Spread / Average Target 15,0%
Spread / Lowest Target -37,9%
EPS Revisions
Managers
NameTitle
Rice Powell Chief Executive Officer
Dieter Schenk Chairman-Supervisory Board
Michael Brosnan Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
William P. Johnston Member-Supervisory Board
Sector and Competitors